No Detail Found!

Clinical and Economic Impacts of a Commercial Vaccine Containing Recombinant Antigen against Atrophic Rhinitis in Field Conditions.

Author(s)
Myung Hyee Kim College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, South Korea: Hipra Korea, Inc, 262 Hwangsaeul-ro, Bundang-gu, Seongam-si, Gyeonggi-do 13557, South Korea
SungJ Yoo College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, South Korea
Taeyong Kwon College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, South Korea
SangH Jae College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, South Korea
DongUk Lee College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, South Korea
Jeongjae Byun College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, South Korea
Jeongyeon Shin College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, South Korea
Sangwon Seo College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, South Korea: Hipra Korea, Inc, 262 Hwangsaeul-ro, Bundang-gu, Seongam-si, Gyeonggi-do 13557, South Korea
YoungS Lyoo College of Veterinary Medicine, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, South Korea
Abstract
Atrophic rhinitis (AR) is an important disease continuously causing economic losses to pig industry. Due to the detrimental effects on growth performance, antibiotics have been widely used to treat the bacterial diseases in the field. As the concerns about bacterial resistance to antibiotics increase, there is a growing need for the evaluation of AR vaccine that can reflect actual cost and benefits. However, until now, only limited research data have been available. Therefore, in this study, the systemic analyses of clinical and economic benefits by AR vaccination under field conditions were conducted. The trials were performed using a bivalent commercial vaccine containing Bordetella bronchiseptica bacterin and recombinant Type D Pasteurella multocida toxin in three different commercial pig farms endemic for AR. Significant higher levels of colostral antibodies and those passive transfer were detected from vaccinated sows to their offspring compared to non-vaccinated groups. As predicted on serological data, notably better clinical protection from the deleterious effects of AR was identified in piglets born to the vaccinated sows based on body weight, rearing period, and gross nasal scores. Moreover, vaccination on sows delivered a return on investment at least ten times the cost of vaccination. Collectively, these favorable clinical and economic effects in the commercial farms sufficiently support the necessity and significance of AR vaccination on sows.
Publication Details
Page(s) 394-398
Published Journal: Pakistan Veterinary Journal, Volume: 38, Issue: 4, Year: 2018

Request the full text from PASTIC

Keywords
Atrophic rhinitis Clinical protection Vaccine
References
Ackermann , MR,DeBeyMC,RegisterKB, 1994.Tonsil and turbinate colonization by toxigenic and nontoxigenic strains of Pasteurella multocida in conventionally raised swine,J Vet Diagn Invest 6 375 -7
ChoiYK,GoyalSM,JooHS, 2003.Retrospective analysis of etiologic agents associated with respiratory diseases in pigs,Can Vet J 44 735 -7
DaviesRL,MacCorquodaleR,BaillieS, 2003.Characterization and comparison of Pasteurella multocida strains associated with porcine pneumonia and atrophic rhinitis,J Med Microbiol 52 59 -67
DominickMA,RimlerRB, 1988.Turbinate osteoporosis in pigs following intranasal inoculation of purified Pasteurella toxin: histomorphometric and ultrastructural studies,Vet Pathol 25 17 -27
DonkoT,KovacsM,MagyarT, 2005.Association of growth performance with atrophic rhinitis and pneumonia detected at slaughter in a conventional pig herd in Hungary,ActaVet Hung 53 287 -98
FurianTQ,BorgesKA,LavinikiV, 2016.Virulence genes and antimicrobial resistance of Pasteurella multocida isolated from poultry and swine,Braz J Microbiol 47 210 -6
GuS,FanY,HuD, 2017.Evaluation of an experimental vaccine for atrophic rhinitis in Piglets,J Vaccines Vaccin 8 353 -
GwaltneySM,GalvinRJ,RegisterKB, 1997.Effects of Pasteurella multocida toxin on porcine bone marrow cell differentiation into osteoclasts and osteoblasts,Vet Pathol 34 421 -30
HoriguchiY, 2012.Swine atrophic rhinitis caused by Pasteurella multocida toxin and Bordetella dermonecrotic toxin,Curr Top Microbiol Immunol 361 113 -29
HozborD,FouqueF,GuisoN, 1999.Detection of Bordetella bronchiseptica by the polymerase chain reaction,Res Microbiol 150 333 -41
HsuanSL,LiaoCM,HuangC, 2009.Efficacy of a novel Pasteurella multocida vaccine against progressive atrophic rhinitis of swine,Vaccine 27 2923 -9
KangML,KangSG,Jiang Hl, 2008.Chitosan microspheres containing Bordetella bronchiseptica antigens as novel vaccine against atrophic rhinitis in Pigs,J Microbiol Biotechnol 18 1179 -85
LiaoCM,HuangC,HsuanSL, 2006.Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs,Vaccine 24 27 -35
LiuH,ZhaoZ,XiX, 2017.Occurrence of Pasteurella multocida among pigs with respiratory disease in China between 2011 and 2015,Ir Vet J 70 2 -
Lopes AntunesAC,ErsbollAK,BihrmannK, 2017.Mortality in Danish Swine herds: Spatio-temporal clusters and risk factors,Prev Vet Med 145 41 -8
MagyarT,DonkoT,RepaI, 2013.Regeneration of toxigenic Pasteurella multocida induced severe turbinate atrophy in pigs detected by computed tomography,BMC Vet Res 9 222 -
MagyarT,KingVL,KovacsF, 2002.Evaluation of vaccines for atrophic rhinitis-a comparison of three challenge models,Vaccine 20 1797 -802
MagyarT,LaxAJ,AtrophicRhinitis,Polymicrobial diseases (K A Brogden and J M Guthmiller, 2002., 169 -97
MullanPB,LaxAJ, 1998.Pasteurella multocida toxin stimulates bone resorption by osteoclasts via interaction with osteoblasts,Calcif Tissue Int 63 340 -5
ScheidtAB,MayroseVB,HillMA, 1990.Relationship of growth performance to pneumonia and atrophic rhinitis detected in pigs at slaughter,J Am Vet Med Assoc 196 881 -4
TownsendKM,BoyceJD,ChungJY, 2001.Genetic organization of Pasteurella multocida cap Loci and development of a multiplex capsular PCR typing system,J Clin Microbiol 39 924 -9
van DiemenPM,de Vries ReilinghG, 1994.Intranasal administration of Pasteurella multocida toxin in a challengeexposure model used to induce subclinical signs of atrophic rhinitis in pigs,Am J Vet Res 55 49 -54
WilsonBA,HoM,, 2013.Pasteurella multocida: from zoonosis to cellular microbiology,Clin Microbiol Rev 26 631 -55
YehJC,LoDY,ChangSK, 2017.Antimicrobial susceptibility, serotypes and genotypes of Pasteurella multocida isolates associated with swine pneumonia in Taiwan,Vet Rec 181 323 -
ZimmermanJJ,KarrikerLA,RamirezA,swine (K. B Register , S L,Brockmeier , M F de Jong, 2012., 798 810 -
0

Citations

0

Downloads

96

Views